Swift Biosciences Integrated DNA Technologies Acquires Swift Biosciences The acquisition is IDT's first since being bought by Danaher and is a departure from its previous acquisitions of oligo synthesis businesses. Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day. Swift Biosciences, Arbor Biosciences Partner on Targeted NGS Workflow for SARS-CoV-2 The workflow combines Swift's Adaptase technology and RNA library kits with Arbor's myBaits technology for hybridization-based target enrichment of the virus. Swift Biosciences, LGC BioSearch Partner on Targeted Sequencing for Ag-Bio LGC will be Swift's worldwide partner for amplicon-based targeted sequencing assays for genotyping AgBio samples, including crop species and animals. New Products Posted to GenomeWeb: Agilent, Swift Biosciences, Opentrons, NIPD Genetics Jan 14, 2020 MGI Tech, Swift Biosciences to Jointly Market Library Prep Products in Europe and Asia Pacific Sep 6, 2019 New Products Posted to GenomeWeb: Swift Biosciences, Fluidigm, Xifin Nov 30, 2018 New Products Posted to GenomeWeb: Qiagen, Swift Biosciences, OncoDNA, More Aug 31, 2018 New Products Posted to GenomeWeb: Swift Biosciences, Empirical Bioscience, Xifin Jul 20, 2018 New Products Posted to GenomeWeb: Swift Biosciences, MNG Laboratories, AMS Biotechnology May 23, 2018 Swift Biosciences, Genomenon to Co-Market NGS Panel Design Service Apr 27, 2018 New Products Posted to GenomeWeb: Qiagen, Siemens Healthineers, Swift Biosciences, More Apr 6, 2018 New Products Posted to GenomeWeb: Swift Biosciences, MNG Laboratories, LifeMap Sciences Jun 29, 2017 Swift Biosciences Raises $12.2M Dec 28, 2016 Endometrial Cancer Mutations Detected in Uterine Lavage Samples Sep 29, 2016 Active Motif, Swift Biosciences to Collaborate on ChiP-Seq Tech Mar 9, 2016 Swift and TATAA Announce Partnership to Expand European Presence Feb 10, 2016 Silicon Biosystems, Swift Ink Deal to Join NGS, Tumor Cell Isolation Technologies Feb 9, 2016 Sophia Genetics Partners with Swift Biosciences to Offer MDx Solution Oct 27, 2015 Horizon Discovery, Swift Biosciences Partner on NGS Reference Standards for Oncology Aug 5, 2015 NOAA, Swift Bio Scientists Partner to Create DNA Libraries of Endangered Vaquita Porpoise Premium Jun 2, 2015 Swift Bio, Fluxion Develop Liquid Biopsy Workflow Nov 12, 2013 New Products: Agilent's SureSelect for Ion Proton; DNAStar's Apps for BaseSpace; More Premium Oct 17, 2013 Swift Bio Completes $7M Series B Financing Jul 2, 2013 New Products: Life Tech's AmpliSeq Exome; Swift Biosciences' Accel-NGS; Genome-euro Premium Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.